
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : iPSC-EC
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Karis Bio
Deal Size : Undisclosed
Deal Type : Partnership
Cellino and Karis Bio Develop Nebula-Powered iPSC Therapy for Heart Disease
Details : The partnership aims to industrialize the world’s first clinical-stage autologous iPSC-derived cell therapy for peripheral artery disease (PAD) and coronary artery disease (CAD).
Product Name : iPSC-EC
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
April 15, 2025
Lead Product(s) : iPSC-EC
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Karis Bio
Deal Size : Undisclosed
Deal Type : Partnership
